Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor

Movement Disorders

Volumn 26, Issue 11, 2011, Pages 2073-2080

  Haubenberger, Dietrich ^a,b   Kalowitz, Daniel ^c   Nahab, Fatta B ^d   Toro, Camilo ^e   Ippolito, Dominic ^f   Luckenbaugh, David A ^g   Wittevrongel, Loretta ^a   Hallett, Mark ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^f DUKE UNIVERSITY   (United States)

^g NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Digitizing tablet; Essential tremor; Ethanol; Spiral analysis; Spirography

Indexed keywords

ALCOHOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); DAILY LIFE ACTIVITY; DIGITAL SPIRAL ANALYSIS; ESSENTIAL TREMOR; FAHN TOLOSA MARIN TREMOR RATING SCALE; FEMALE; FOURIER TRANSFORMATION; HUMAN; MALE; MOTOR DYSFUNCTION; PRIORITY JOURNAL; RATING SCALE; SPIROGRAPHY; VISUAL STIMULATION;

ACTIVITIES OF DAILY LIVING; AGED; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CONTROLLED CLINICAL TRIALS AS TOPIC; DIAGNOSIS, COMPUTER-ASSISTED; ESSENTIAL TREMOR; ETHANOL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR SKILLS; MOVEMENT; OUTCOME ASSESSMENT (HEALTH CARE); REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 80052969286     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23808     Document Type: Article

References (23)

1. Benito-Leon J, Bermejo-Pareja F, Morales JM, Vega S, Molina JA. Prevalence of essential tremor in three elderly populations of central Spain. Mov Disord 2003; 18: 389-394.
2. Dogu O, Sevim S, Camdeviren H, et al. Prevalence of essential tremor: door-to-door neurologic exams in Mersin Province, Turkey. Neurology 2003; 61: 1804-1806.
3. Wenning G, Kiechl S, Seppi K, et al. Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a population-based study. Lancet Neurol 2005; 4: 815-820.
4. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 1998; 13(Suppl 3): 2-23.
5. Louis ED, Barnes L, Albert SM, et al. Correlates of functional disability in essential tremor. Mov Disord 2001; 16: 914-920.
6. Zesiewicz TA. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2005; 64: 2008-2020.
7. Fahn S, Tolosa E, Marin C. Clinical Rating Scale for Tremor. In: Jankovic J, Tolosa E, editors. Parkinson's Disease and Movement Disorders. Munich, Germany: Urban und Schwarzenberg; 1988: 271-280.
8. Elble R. The Essential Tremor Rating Assessment Scale (TETRAS). In: Tremor Research Group (TRG); 2008.
9. Bain PG, Findley LJ, Atchison P, et al. Assessing tremor severity. J Neurol Neurosurg Psychiatry 1993; 56: 868-873.
10. Lorenz D. No benefit of 3, 4-diaminopyridine in essential tremor: a placebo-controlled crossover study. Neurology 2006; 66: 1753-1755.
11. Lorenz D, Papengut F, Frederiksen H, et al. Evaluation of a screening instrument for essential tremor. Mov Disord 2008; 23: 1006-1012.
12. Ondo W, Hunter C, Vuong KD, Schwartz K, Jankovic J. Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. Mov Disord 2000; 15: 678-682.
13. Shill HA, Bushara KO, Mari Z, Reich M, Hallett M. Open-label dose-escalation study of oral 1-octanol in patients with essential tremor. Neurology 2004; 62: 2320-2322.
14. Elble RJ, Sinha R, Higgins C. Quantification of tremor with a digitizing tablet. J Neurosci Meth 1990; 32: 193-198.
15. Pullman SL. Spiral analysis: a new technique for measuring tremor with a digitizing tablet. Mov Disord 1998; 13(Suppl 3): 85-89.
16. Saunders-Pullman R, Derby C, Stanley K, et al. Validity of spiral analysis in early Parkinson's disease. Mov Disord 2008; 23: 531-537.
17. Elble RJ, Lyons KE, Pahwa R. Levetiracetam is not effective for essential tremor. Clin Neuropharmacol 2007; 30: 350-356.
18. Hsu A, Piboolnurak P, Floyd A, et al. Spiral analysis in Niemann-Pick disease type C. Mov Disord 2009; 24: 1984-1990.
19. Kraus PH, Hoffmann A. Spiralometry: computerized assessment of tremor amplitude on the basis of spiral drawing. Mov Disord 2010; 25: 2164-2170.
20. Zeuner KE, Molloy FM, Shoge RO, Goldstein SR, Wesley R, Hallett M. Effect of ethanol on the central oscillator in essential tremor. Mov Disord 2003; 18: 1280-1285.
21. Bushara KO, Goldstein SR, Grimes GJ, Burstein AH, Hallett M. Pilot trial of 1-octanol in essential tremor. Neurology 2004; 62: 122-124.
22. Ondo W, Wang A, Thomas M, Vuong K. Evaluating factors that can influence spirography ratings in patients with essential tremor. Parkinsonism Relat Disord 2005; 11: 45-48.
23. Elble RJ, Pullman SL, Matsumoto JY, et al. Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales. Brain 2006; 129: 2660-2666.